Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IGF2BP2 pseudogene 3 (IGF2BP2P3) is a pseudogene and does not encode a functional protein or act as a biological target. The parent gene, IGF2BP2 (insulin-like growth factor 2 mRNA-binding protein 2), encodes an RNA-binding protein implicated in various physiological and disease processes, including metabolism, embryonic development, and cancer[4][5][6]. However, IGF2BP2P3 lacks coding potential and functional roles characteristic of receptor, transporter, or enzyme targets. There is currently no evidence that IGF2BP2P3 functions as a therapeutic target, biomarker, or is involved in mechanistic drug actions. The biological significance of such pseudogenes is limited to their potential as transcriptional noise or, infrequently, as regulators via RNA-mediated mechanisms, but there is no direct evidence of such a role for IGF2BP2P3.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IGF2BP2 pseudogene 3 (IGF2BP2P3).